THY1 and leukemia: In particular, the study of Hayakawa et al. showed that B cells expressing a transgenic low-affinity anti-Thy-1 BCR undergo malignant transformation only in the presence of the Thy-1 autoantigen, confirming that chronic stimulation with extrinsic low-affinity autoantigen can induce leukemia in vivo [73].